Clinical trial
An Open, Randomized, Multi-center, Phase 2 Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix: the Efficacy and New Biomarkers
NCT02482740 is registered in ClinicalTrials.gov with Buddhist Tzu Chi General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open, Randomized, Multi-center, Phase 2 Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix: the Efficacy and New Biomarkers
- Lead sponsor
- Buddhist Tzu Chi General Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 31, 2015
- Completion date
- June 30, 2017
- Enrollment
- 44 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.